Hyperfine
HYPR
39 hedge funds and large institutions have $12.9M invested in Hyperfine in 2022 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 7 increasing their positions, 5 reducing their positions, and 7 closing their positions.
43% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 7
40% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 5
5% more funds holding
Funds holding: 37 → 39 (+2)
2.14% less ownership
Funds ownership: 29.81% → 27.67% (-2.1%)
5% less capital invested
Capital invested by funds: $13.6M → $12.9M (-$736K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HM
HealthCor Management
New York
|
+$1.03M |
| 2 |
JFG
Jefferies Financial Group
New York
|
+$272K |
| 3 |
APG Asset Management
Amsterdam,
Netherlands
|
+$95.1K |
| 4 |
CI
CAZ Investments
Houston,
Texas
|
+$43.2K |
| 5 |
RPC
Rossmore Private Capital
Glastonbury,
Connecticut
|
+$37.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
-$810K |
| 2 |
PA
Perceptive Advisors
New York
|
-$751K |
| 3 |
GCM
Glenview Capital Management
New York
|
-$490K |
| 4 |
Wells Fargo
San Francisco,
California
|
-$121K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$57K |
HYPR Hedge Fund Activity: Q4 2022 in Review
39 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Hyperfine (HYPR) for Q4 2022, worth a combined $12.9M — down 5.4% from $13.6M a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new HYPR positions and 7 closed out — a net gain of 3 holders — while 7 added to existing stakes and 5 trimmed.
The largest buyer was HealthCor Management, adding an estimated $1.03M. The largest seller was ARK Investment Management, exiting entirely with an estimated $810K sold.
- 39 institutional investors held Hyperfine (HYPR) as of Q4 2022, up from 37 in Q3 2022.
- Funds reported $12.9M of Hyperfine stock for Q4 2022, down 5.4% quarter-over-quarter.
- 10 funds opened new Hyperfine positions in Q4 2022 and 7 closed out, a net change of +3 holders.
- The largest Hyperfine buyer in Q4 2022 was HealthCor Management, an estimated $1.03M added.
- The largest Hyperfine seller in Q4 2022 was ARK Investment Management, an estimated $810K sold.
Based on aggregated 13F filings for Q4 2022.